Greenwood Capital Associates’s Aehr Test Systems AEHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-9,044
Closed -$335K 285
2026
Q1
$335K Buy
+9,044
New +$289K 0.04% 252
2025
Q1
Sell
-32,693
Closed -$544K 235
2024
Q4
$544K Buy
32,693
+5,026
+18% +$67K 0.07% 178
2024
Q3
$356K Sell
27,667
-574
-2% -$8.3K 0.05% 206
2024
Q2
$315K Buy
28,241
+7,422
+36% +$86.5K 0.04% 210
2024
Q1
$258K Sell
20,819
-227
-1% -$3.78K 0.03% 231
2023
Q4
$558K Buy
21,046
+2,023
+11% +$59K 0.07% 182
2023
Q3
$869K Sell
19,023
-4,981
-21% -$231K 0.13% 148
2023
Q2
$990K Buy
24,004
+3,342
+16% +$110K 0.14% 130
2023
Q1
$641K Sell
20,662
-10,980
-35% -$354K 0.09% 170
2022
Q4
$636K Buy
31,642
+4,802
+18% +$103K 0.1% 155
2022
Q3
$378K Buy
+26,840
New +$361K 0.06% 191

Other funds holding AEHR

Greenwood Capital Associates's AEHR Position: Q2 2026 in Review

Greenwood Capital Associates sold out of Aehr Test Systems (AEHR) in Q2 2026, closing a stake of 9,044 shares — an estimated $335K sold.

Greenwood Capital Associates first reported a position in AEHR in Q3 2022 and held it in 11 quarters. The position peaked at $990K in Q2 2023. 51 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

  • Greenwood Capital Associates reported no remaining Aehr Test Systems position as of Q2 2026 after selling out during the quarter.
  • Greenwood Capital Associates sold 9,044 Aehr Test Systems shares in Q2 2026, an estimated $335K.
  • Greenwood Capital Associates first reported a position in Aehr Test Systems in Q3 2022 and held it in 11 quarters.
  • Greenwood Capital Associates's Aehr Test Systems position peaked at $990K in Q2 2023.
  • 51 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on Greenwood Capital Associates's 13F filing for Q2 2026, filed 28 Jul 2026.